HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS: A SEER-MEDICARE ANALYSIS

被引：0
|
作者：
Stein, E. M. [1 ]
Latremouille-Viau, D. [2 ]
Shi, S. [2 ]
Guerin, A. [2 ]
Wu, E. [3 ]
Bonifacio, G. [4 ]
Cao, X. [4 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Anal Grp Inc, Montreal, PQ, Canada
[3] Anal Grp Inc, Boston, MA USA
[4] Novartis Pharmaceut, E Hanover, NJ USA
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDG20
引用
收藏
页码：S132 / S133
页数：2
相关论文
共 50 条
  • [41] Intensive Care Unit Utilization Among Patients With Lung Cancer In The Seer-Medicare Registry
    Cooke, C. R.
    Feemster, L. C.
    Wiener, R. S.
    Slatore, C. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [42] Genomic Biomarkers to Predict Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Sekeres, Mikkael A.
    Bejar, Rafael
    Komrokji, Rami S.
    Barnard, John
    Al-Issa, Karam
    Przychodzen, Bartlomiej P.
    Hirsch, Cassandra M.
    Steensma, David P.
    DeZern, Amy E.
    Roboz, Gail J.
    Garcia-Manero, Guillermo
    Ebert, Benjamin L.
    Maciejewski, Jaroslaw P.
    BLOOD, 2017, 130
  • [43] Persistence to hypomethylating agents and clinical and economic outcomes among patients with myelodysplastic syndromes
    Cheng, Wendy Y.
    Satija, Ambika
    Cheung, Hoi Ching
    Hill, Kala
    Wert, Tim
    Laliberte, Francois
    Lefebvre, Patrick
    HEMATOLOGY, 2021, 26 (01) : 261 - 270
  • [44] Penile Implant Utilization Following Treatment for Prostate Cancer: Analysis of the SEER-Medicare Database
    Tal, Raanan
    Jacks, Lindsay M.
    Elkin, Elena
    Mulhall, John P.
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 (06): : 1797 - 1804
  • [45] Impact of Hypomethylating Agents on Cardiovascular Disease Risk Among Patients with Myelodysplastic Syndromes
    Herrera, Diego Adrianzen
    Sparks, Andrew
    Gergi, Mansour
    Giorgio, Katherine
    Lutsey, Pamela
    Zakai, Neil
    BLOOD, 2023, 142
  • [46] The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes
    Wang, Rong
    Gross, Cary P.
    Frick, Kevin
    Xu, Xiao
    Long, Jessica
    Raza, Azra
    Galili, Naomi
    Zikria, Jennifer
    Guan, Yongtao
    Ma, Xiaomei
    LEUKEMIA RESEARCH, 2012, 36 (11) : 1370 - 1375
  • [47] Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
    Mrinmayee Lakkad
    Bradley Martin
    Chenghui Li
    Sarah Harrington
    Lindsey Dayer
    Jacob T. Painter
    Journal of Cancer Survivorship, 2023, 17 : 917 - 950
  • [48] Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
    Lakkad, Mrinmayee
    Martin, Bradley
    Li, Chenghui
    Harrington, Sarah
    Dayer, Lindsey
    Painter, Jacob T.
    JOURNAL OF CANCER SURVIVORSHIP, 2023, 17 (04) : 917 - 950
  • [49] Treatment Patterns, Clinical Outcomes, Health Care Resource Utilization and Costs in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the United States: An Analysis of SEER-Medicare Data
    Swami, Umang
    Aggarwal, Himani
    Zhou, Mo
    Jiang, Shan
    Kim, Jeri
    Li, Weiyan
    Laliberte, Francois
    Emond, Bruno
    Agarwal, Neeraj
    CLINICAL GENITOURINARY CANCER, 2023, 21 (05) : 517 - 529
  • [50] Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis
    Karim, Mohammad A.
    Singal, Amit G.
    Kum, Hye Chung
    Lee, Yi-Te
    Park, Sulki
    Rich, Nicole E.
    Noureddin, Mazen
    Yang, Ju Dong
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (05): : 874 - 883
12345